Vaccines Market Research Reports & Industry Analysis
Key issues in the global vaccine market today include product safety, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.
The topic of vaccine safety became prominent during the mid 1970’s with increases in lawsuits filed on behalf of those presumably injured by the diphtheria, pertussis, and tetanus (DPT) vaccine. To respond to public health concerns, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, which in turn led to the creation of the National Vaccine Program Office (NVPO) within the Department of Health and Human Services (DHHS). NCVIA requires that all healthcare providers who administer vaccines containing diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b and varicella provide a Vaccine Information Statement (VIS) to the vaccine recipient, their parent or legal guardian prior to each dose. Each VIS contains a brief description of the disease as well as the risks and benefits of the vaccine. The NCVIA also mandated that all healthcare providers report certain adverse events that occur following vaccination. As a result, the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink Project (VSD) were established in 1990. VAERS provides a mechanism for the collection and analysis of adverse events associated with vaccines currently licensed in the U.S.; VSD involved forming partnerships with four large health maintenance organizations (HMOs) to continually monitor vaccine safety. The National Vaccine Injury Compensation Program, which was also created by NCVIA, compensates those individuals who have been injured by vaccines on a no-fault basis. On a global basis, the World Health Organization (WHO) is actively involved in ensuring the quality of vaccines.
Vaccines Industry Research & Market Reports
-
Global Human Vaccine Market 2018-2022
... mortality rates, and life expectancy. Technavio’s analysts forecast the Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022. Covered in this report The report covers the present scenario and ... Read More
-
Global Viral Vector Manufacturing Markets and Technologies Through 2022
... manufacturing market, and potential application sectors across various industries. The viral vector vaccine manufacturing market is broken down by types, application and diseases. Revenue forecasts from 2017 to 2022 are given for each product type, ... Read More
-
Global Cancer Vaccine Partnering 2012-2018: Deal trends, players, financials and forecasts
... the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value This report provides ... Read More
-
Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials
... detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors ... Read More
-
Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecasts to 2023
... is projected to grow at a CAGR of 21.7% during the forecast period.” The global viral clearance market is expected to reach USD 724.5 million by 2023 from an estimated USD 271.2 million in 2018, ... Read More
-
Global Vaccine Refrigerators Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
... need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradation of vaccines and other products, along with options like alarms and backup ... Read More
-
HIDA 2018 Influenza Vaccine Production & Distribution Market Brief
... chain and key information from the eighth annual “HIDA Flu Products Survey” of distributors conducted in May 2018. The survey demonstrates the essential role that distributors will serve during the 2018-2019 flu season by helping ... Read More
-
Global Vaccines
... segmented in terms of: pneumococcal; combination; measles, mumps, and rubella; varicella; and other pediatric vaccines such as polio, hepatitis, and haemophilus influenzae type b. Global demand for adult vaccines is segmented in terms of: influenza; ... Read More
-
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Peptide Cancer Vaccine Market 2018, Forecast to 2023
... clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. Scope of the Report: This ... Read More
-
Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)
... Segments provides a complete global revenue summary, including the total global market for preventive vaccines by type for 2015 to 2024 (pediatric total: combinations, hepatitis, haemophilus influenzae type B, measles, mumps and rubella, pneumococcal, poliovirus, ... Read More
-
Veterinary Vaccines - Global Market Outlook (2017-2026)
... a CAGR of 6.9% from 2017 to 2026. Growing figure of livestock disease, Increasing Adoption of Companion Animals and Rising frequency of Zoonotic diseases are some of the factors that are fuelling the market growth. ... Read More
-
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) BCG Vaccine Market 2018, Forecast to 2023
... the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of ... Read More
-
Global Vaccines Market with focus on China: Industry Analysis & Outlook (2018-2022)
... special cells to fight it off. The immune system is not naturally strong enough to prevent a disease from seriously harming a person. But there’s a way to give the immune system a boost, it ... Read More
-
Rubella (German Measles) Global Clinical Trials Review, H2, 2018
... report provides top line data relating to the clinical trials on Rubella (German Measles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024
... is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction ... Read More
-
Adult Vaccine Market, Global Analysis By Disease (Influenza, Cervical Cancer, Zoster, MMR , Pneumonia, Meningitis, Hepatitis, Tap , Varicella & Travel & Miscellaneous Vaccine) & Companies
... 22 Billion by the year 2024. Vaccination can help prevent certain diseases in all the people. Nearly all countries across the globe have introduced a well-organized National immunization Programs in their vaccination schedule to overcome ... Read More
-
Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies
... the year 2024. Increasing government and non-government funding for the development of new vaccines, along with raising awareness about the benefits of vaccination, is certainly expected to positively drive the market growth in the coming ... Read More
-
Microcarrier Market by Equipment (Bioreactor, Culture Vessels, Cell Counter, Filtration System), Consumables (Sera, Serum Free Media), Microcarriers (Cationic, Collagen, Protein coated), Application (Vaccines, Cell Therapy) - Global Forecast to 2023
... therapies to drive growth in the microcarriers market” The microcarriers market is projected to reach USD 1.61 billion by 2023 from USD 1.20 billion in 2018, at a CAGR of 6.0%. Growth in this market ... Read More
-
Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vacci
... Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)” Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, ... Read More
-
Global Foot and Mouth Disease (FMD) Vaccines Market - Segmented by Vaccine Type, by Animal Type and Geography - Growth, Trends, and Forecast (2018 - 2023)
... is expected to register a growth rate of nearly 7.4% during the forecast period, 2018-2023. Foot and mouth disease occurs in the livestock animal population and poses a serious threat around the world. Increasing demand ... Read More
-
The 2019-2024 Outlook for Vaccines and Toxiods for Human Use Excluding Allergens and Diagnostics in the United States
... and diagnostics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For ... Read More
-
The 2019-2024 Outlook for Pediatric Drugs and Vaccines in the United States
... demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its ... Read More
-
The 2019-2024 Outlook for Human Influenza Vaccines in the United States
... millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and ... Read More
-
The 2019-2024 Outlook for Biological Veterinary Vaccines, Bacterins, Toxoids, Other Antigens, and Other Biological Products in the United States
... and other biological products across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United ... Read More
-
Global Influenza Vaccines Market Outlook 2018-2028
... in 2018. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. Visiongain’s new study tells you and tells you NOW. In this ... Read More
